← Back to Search

Mindfulness-Based Intervention

Mindfulness-Based Intervention for Autism Spectrum Disorder

N/A
Waitlist Available
Led By Nicole Matthews, Ph.D
Research Sponsored by Southwest Autism Research & Resource Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adolescents must be ages 13 to 18 years
English speaking: Adolescents and their parent/caregivers must be English-speaking because the screening and behavioral measures are in English, as well as the intervention content
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-intervention (8 weeks); 2-month follow-up
Awards & highlights

Study Summary

This trial will evaluate an 8-week mindfulness program for teens w/ autism & their caregivers to improve mental health & quality of life.

Who is the study for?
This trial is for English-speaking teens aged 13-18 with Autism Spectrum Disorder in Arizona, who can attend most group meetings and have no intellectual disabilities (IQ above 70). They must not have conditions preventing participation in video calls or active suicidal thoughts.Check my eligibility
What is being tested?
The effectiveness of 'MINDful TIME', an 8-week program combining psychoeducational groups via videoconferencing and a meditation app, aimed at improving mental health for autistic adolescents and their caregivers.See study design
What are the potential side effects?
Since this intervention involves mindfulness practices rather than medication, typical medical side effects are not expected. However, participants may experience emotional discomfort when engaging with new mental health practices.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 13 and 18 years old.
Select...
I, and my parent or caregiver if I'm an adolescent, can speak English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-intervention (8 weeks); 2-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-intervention (8 weeks); 2-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean Change from Baseline in Child and Adolescent Mindfulness Measure (CAMM) Scores
Mean Change from Baseline in Children's Depression Inventory (CDI) Scores
Mean Change from Baseline in Multidimensional Anxiety Scale for Children (MASC) Scores
Secondary outcome measures
Mean Change from Baseline in Adaptive Behavior Assessment System (ABAS-3) Scores
Mean Change from Baseline in Beck Youth Inventories (BYI) Scores
Mean Change from Baseline in Behavior Rating Inventory of Executive Function (BRIEF) Scores
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Mindfulness-based InterventionExperimental Treatment1 Intervention
The intervention will include weekly 90-minute group meetings held online through Zoom. Adolescents and parents will meet in separate groups and will learn about mindfulness-based strategies that can be used to manage and reduce stress, anxiety, and depression. They will also learn evidence-based strategies to complete daily guided mindfulness meditations using Ten Percent Happier, a commercially-available mobile app. Participants will be encouraged to meditate using the mobile app for at least 10 minutes each day during and after the 8-week intervention.
Group II: Delayed Treatment ControlActive Control1 Intervention
Participants will be instructed to engage in treatment as usual during their 8-week wait period. After their wait period, participants will be enrolled in the mindfulness-based intervention.

Find a Location

Who is running the clinical trial?

Southwest Autism Research & Resource CenterLead Sponsor
6 Previous Clinical Trials
886 Total Patients Enrolled
6 Trials studying Autism Spectrum Disorder
886 Patients Enrolled for Autism Spectrum Disorder
Arizona State UniversityOTHER
279 Previous Clinical Trials
107,447 Total Patients Enrolled
8 Trials studying Autism Spectrum Disorder
693 Patients Enrolled for Autism Spectrum Disorder
Blue Cross Blue Shield of Arizona Foundation for Community and Health AdvancementUNKNOWN

Media Library

MINDful TIME (Mindfulness-Based Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05685589 — N/A
Autism Spectrum Disorder Research Study Groups: Mindfulness-based Intervention, Delayed Treatment Control
Autism Spectrum Disorder Clinical Trial 2023: MINDful TIME Highlights & Side Effects. Trial Name: NCT05685589 — N/A
MINDful TIME (Mindfulness-Based Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05685589 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are senior citizens being included in this experiment?

"The parameters for entry into this clinical trial dictate that prospective patients must be between 13 and 18 years of age."

Answered by AI

Is it still possible to apply for participation in this experiment?

"Affirmative. According to the information found on clinicaltrials.gov, this trial is actively searching for participants since its original posting on April 1st 2023 and its most recent update of May 1st 2023. The study aims to enroll 40 patients from a single site."

Answered by AI

What is the current capacity for patients enrolled in this clinical trial?

"Affirmative. According to clinicaltrials.gov, this experiment is actively recruiting applicants; it was initiated on April 1st 2023 and most recently modified on May 1st of the same year. The trial aims to include 40 patients from a single medical site."

Answered by AI

Do I qualify to partake in this trial?

"This medical research has recruited 40 autistic minors aged between 13 and 18. To qualify for inclusion, applicants must satisfy the following: possess a formal clinical diagnosis of ASD authenticated by study personnel; agree to be randomized into either an active treatment group or delayed-treatment control group; commit to attending 7 out of 8 sessions; fluency in English since all assessments and interventions are conducted in English only; residence within Arizona state boundaries (USA)."

Answered by AI

What objective is this scientific endeavor attempting to achieve?

"This medical trial plans to track the changes in Multidimensional Anxiety Scale for Children (MASC) scores over 8 weeks, with a 2-month follow up. Secondary objectives include measuring adolescent wellbeing using World Health Organization-Five Wellbeing Index (WHO-5), adaptive skills via Adaptive Behavior Assessment System (ABAS-3), and social impairment within autism spectrum using Social Responsiveness Scale (SRS-2)."

Answered by AI
~18 spots leftby Mar 2025